Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07)

Jakob R. Passweg, MD, MS, Thomas Pabst, Sabine Blum, Mario Bargetzi, Hong Sun, Dominik Heim, MD, Georg Stussi, MD, Michael Gregor, Leda Leoncini, Sandrine Meyer-Monard, MD, Peter Brauchli, Yves Chalandon, MD

Blood (2010) 116 (21): 2181.

https://doi.org/10.1182/blood.V116.21.2181.2181

Published: 2010

Journal Articles

Very long-term outcome of acute promyelocytic leukemia after treatment with all- trans retinoic acid and chemotherapy: the European APL Group experience

Blood (2010) 115 (9): 1690–1696.

https://doi.org/10.1182/blood-2009-07-233387

Published: 2010

Journal Articles

Very Long Term Outcome of Acute Promyelocytic Leukemia After Treatment with All Trans Retinoic Acid and Chemotherapy: The European APL Group Experience.

Blood (2009) 114 (22): 2088.

https://doi.org/10.1182/blood.V114.22.2088.2088

Published: 2009

Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) in the Elderly: A Joint Analysis of the French -Belgian-Swiss and PETHEMA Groups.

Blood (2009) 114 (22): 845.

https://doi.org/10.1182/blood.V114.22.845.845

Published: 2009

Journal Articles

Expansion of Donor NK Cells for Adoptive Immunotherapy in Haploidentical Stem Cell Transplantation: A Phase I–II Study

Uwe Siegler, PhD, Sandrine Meyer-Monard, MD, Simon Jörger, MD, Martin Stern, MD, Andre Tichelli, MD, Alois Gratwohl, MD, Aleksandra Wodnar-Filipowicz, PhD, Christian Kalberer, PhD

Blood (2008) 112 (11): 3893.

https://doi.org/10.1182/blood.V112.11.3893.3893

Published: 2008

Journal Articles

Impact of ATRA Duration during the Induction Treatment of Newly Diagnosed APL

Blood (2008) 112 (11): 139.

https://doi.org/10.1182/blood.V112.11.139.139

Published: 2008

Journal Articles

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

Blood (2008) 111 (3): 1078–1084.

https://doi.org/10.1182/blood-2007-07-099978

Published: 2008

Journal Articles

Intraplatform Reproducibility and Technical Precision of Gene Expression Profiling in Four Laboratories Investigating 112 Leukemia Samples: The DACH Study.

Alexander Kohlmann, PhD, Elisabeth Haschke-Becher, MD, Barbara Wimmer, PhD, Ariana Huber-Wechselberger, PhD, Sandrine Meyer-Monard, MD, Heike Huxol, Uwe Siegler, PhD, Michel Rossier, PhD, Thomas Matthes, MD, Michela Rebsamen, PhD, Adeline Diemand, Alberto Chiappe, Sonja Rauhut, Wei-min Liu, PhD, Andrea Johnson, PhD, Lothar Wieczorek, PhD, Torsten Haferlach, MD

Blood (2007) 110 (11): 2383.

https://doi.org/10.1182/blood.V110.11.2383.2383

Published: 2007

Journal Articles

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

André Tichelli, Christoph Bucher, Alicia Rovó, Georg Stussi, Martin Stern, Michael Paulussen, Jörg Halter, Sandrine Meyer-Monard, Dominik Heim, Dimitrios A. Tsakiris, Barbara Biedermann, Jakob R. Passweg, Alois Gratwohl

Blood (2007) 110 (9): 3463–3471.

https://doi.org/10.1182/blood-2006-10-054080

Published: 2007

Journal Articles

Role of primacy of birth in HLA-identical sibling transplantation

Christoph Bucher, Martin Stern, Andreas Buser, Dominik Heim, Michael Paulussen, Jörg Halter, Dimitrios Tsakiris, Armin Droll, Sandrine Meyer-Monard, Andre Tichelli, Jakob Passweg, Alois Gratwohl

Blood (2007) 110 (1): 468–469.

https://doi.org/10.1182/blood-2007-02-076257

Published: 2007

Journal Articles

High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.

Andreas S. Buser, MD, Martin Stern, MD, Christoph Bucher, MD, Caroline Arber, MD, Dominik Heim, MD, Joerg Halter, MD, Sandrine Meyer-Monard, MD, Georg Stussi, MD, Andreas Lohri, MD, Michele Ghielmini, MD, Andre Tichelli, MD, Jakob R. Passweg, MD, Alois Gratwohl, MD

Blood (2006) 108 (11): 5352.

https://doi.org/10.1182/blood.V108.11.5352.5352

Published: 2006

Journal Articles

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Jakob R. Passweg, MD, MS, Ulrike Koehl, PhD, Martin Stern, MD, Torsten Tonn, MD, Sandrine Meyer-Monard, MD, Peter Bader, MD, Johannes Rischewski, MD, Jan Soerensen, MD, Michael Paulussen, MD, Alois Gratwohl, MD, Thomas Klingebiel, MD, Andre Tichelli, MD, Dirk Schwabe, MD

Blood (2006) 108 (11): 411.

https://doi.org/10.1182/blood.V108.11.411.411

Published: 2006

Journal Articles

Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD

Alicia Rovó, André Tichelli, Jakob R. Passweg, Dominik Heim, Sandrine Meyer-Monard, Wolfgang Holzgreve, Alois Gratwohl, Christian De Geyter

Blood (2006) 108 (3): 1100–1105.

https://doi.org/10.1182/blood-2006-01-0176

Published: 2006

Journal Articles

Sideroblastic Changes Can Be Recognized in the Erythrogram.

Alicia Rovó, MD, Jakob R. Passweg, MD, Geneviève Favre, MD, Dominik Heim, MD, Sandrine Meyer-Monard, MD, Dimitrios Tsakiris, MD, Alois Gratwohl, MD, André Tichelli, MD

Blood (2005) 106 (11): 4909.

https://doi.org/10.1182/blood.V106.11.4909.4909

Published: 2005

Journal Articles

Hematopoietic Precursor Cell Cultures (CFU-C) in Diagnosis and Prognosis of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML).

Michael Pierre Bernimoulin, MD, Martine Jotterand, PhD, Andre Tichelli, MD, Sandrine Meyer-Monard, MD, Dominik Heim, MD, Alois Gratwohl, MD, Catherine Nissen, MD

Blood (2005) 106 (11): 4918.

https://doi.org/10.1182/blood.V106.11.4918.4918

Published: 2005

Journal Articles

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, Julian Schardt, Myriam Eyer, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, Thomas Pabst

Blood (2005) 106 (4): 1369–1375.

https://doi.org/10.1182/blood-2004-11-4392

Published: 2005

Journal Articles

Complete remission of alopecia universalis after allogeneic hematopoietic stem cell transplantation

Bettina Seifert, Jakob R. Passweg, Dominik Heim, Alicia Rovó, Sandrine Meyer-Monard, Stanislaus Buechner, Andre Tichelli, Alois Gratwohl

Blood (2005) 105 (1): 426–427.

https://doi.org/10.1182/blood-2004-01-0136

Published: 2005

Journal Articles

Donor Hematopoietic Stem Cells Did No Major Contribution to Hair Follicle Repair Either in Short or in Long Term Allogeneic Hematopoietic Stem Cell Transplants Recipients.

Alicia Rovo, MD, Sandrine Meyer-Monard, MD, Dominik Heim, MD, Caroline Arber, MD, Jakob R. Passweg, PD, Alois Gratwohl, Andre Tichelli

Blood (2004) 104 (11): 4167.

https://doi.org/10.1182/blood.V104.11.4167.4167

Published: 2004

Journal Articles

Inv (16) Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin.

Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, Thomas Pabst

Blood (2004) 104 (11): 3388.

https://doi.org/10.1182/blood.V104.11.3388.3388

Published: 2004

Journal Articles

A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)

Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, Dominique Mühlematter, Martine Jotterand, Celine Besse, Nicolas Leupin, Daniel Ratschiller, Jeanette Papp, Gina Kearsey, Stefan Aebi, Hans Graber, Rolf Jaggi, Jean-Marc Lüthi, Sandrine Meyer-Monard, Mark Lathrop, Andreas Tobler, Martin F. Fey

Blood (2002) 100 (5): 1787–1794.

https://doi.org/10.1182/blood.V100.5.1787.h81702001787_1787_1794

Published: 2002

NARROW

5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07)

Very long-term outcome of acute promyelocytic leukemia after treatment with all- trans retinoic acid and chemotherapy: the European APL Group experience

Very Long Term Outcome of Acute Promyelocytic Leukemia After Treatment with All Trans Retinoic Acid and Chemotherapy: The European APL Group Experience.

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) in the Elderly: A Joint Analysis of the French -Belgian-Swiss and PETHEMA Groups.

Expansion of Donor NK Cells for Adoptive Immunotherapy in Haploidentical Stem Cell Transplantation: A Phase I–II Study

Impact of ATRA Duration during the Induction Treatment of Newly Diagnosed APL

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

Intraplatform Reproducibility and Technical Precision of Gene Expression Profiling in Four Laboratories Investigating 112 Leukemia Samples: The DACH Study.

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

Role of primacy of birth in HLA-identical sibling transplantation

High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD

Sideroblastic Changes Can Be Recognized in the Erythrogram.

Hematopoietic Precursor Cell Cultures (CFU-C) in Diagnosis and Prognosis of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML).

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Complete remission of alopecia universalis after allogeneic hematopoietic stem cell transplantation

Donor Hematopoietic Stem Cells Did No Major Contribution to Hair Follicle Repair Either in Short or in Long Term Allogeneic Hematopoietic Stem Cell Transplants Recipients.

Inv (16) Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin.

A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only